BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2009
View Archived Issues
TriN Pharma scientists claim antitumoral triazine compounds and their use in cancer therapy
Read More
Merck KGaA presents Met kinase inhibitors for cancer
Read More
New CB2 agonists discovered at Bristol-Myers Squibb
Read More
Otsuka claims new neuroprotectants and their use in Parkinson's disease
Read More
CNRS patent covers new anticancer agents
Read More
Intravaginal C5A application protects mice from vaginal HIV-1 transmission
Read More
New HIV-1 drug displays excellent in vitro potency against NNRTI-resistant viruses
Read More
Sanofi pasteur initiates phase IIb clinical trial of C. difficile vaccine
Read More
Chi-Med completes enrollment in phase II trial of HMPL-004 in Crohn's disease
Read More
Eisai reviews latest developments from third quarter
Read More
Phase I NKTR-105 study starts dosing in patients with refractory solid tumors
Read More
GSK initiates phase III program for novel type 2 diabetes drug, Syncria
Read More
PRIMA-1 suppresses progestin-induced tumor growth in rats
Read More
Clofazimine acts on target implicated in autoimmune diseases
Read More
Chelsea reports findings from open-label pivotal phase III droxidopa trials
Read More
Galantamine beneficial in elderly patients with severe Alzheimer's disease
Read More
Cubist commences phase I CB-182804 trial in humans
Read More
Depomed initiates phase I DM-1992 trial in Parkinson's disease
Read More
Lux Biosciences initiates LX-214 study for dry eye syndrome
Read More
BioTie initiates E.U. clinical trial of VAP-1 monoclonal antibody BTT-1023 in RA
Read More
Vion files NDA with FDA for oncology therapeutic Onrigin in AML
Read More
Flamel and Merck Serono sign license agreement to apply Medusa technology to therapeutic protein
Read More
Sequella receives SBIR grant from NIH for preclinical development of TB drug SQ-609
Read More
Pixantrone decreases time to complete remission in non-Hodgkin's lymphoma
Read More
Chugai enters license agreement with Romark for nitazoxanide in Japan
Read More
Cipher receives tentative FDA approval for extended-release tramadol
Read More